Phaos Technology Holdings (Cayman) (POAS) Enterprise Value (2024 - 2025)
Phaos Technology Holdings (Cayman) (POAS) posted Enterprise Value of -$54989.0 for Q4 2025, up 43.26% on a QoQ basis from -$96918.3 in Q2 2025.
Phaos Technology Holdings (Cayman) (POAS) Enterprise Value (2024 - 2025) Analysis & Trends
Phaos Technology Holdings (Cayman)'s Enterprise Value history runs 2 years deep, the most recent figure standing at -$54989.0 for Q4 2025.
- Quarterly Enterprise Value changed N/A year-over-year to -$54989.0 in Q4 2025, while the trailing twelve-month figure through Oct 2025 was -$54989.0 (changed N/A YoY) and the FY2025 annual result came in at -$97007.0, up 94.35% from the prior year.
- Enterprise Value was -$54989.0 for Q4 2025 at Phaos Technology Holdings (Cayman), up from -$96918.3 in the prior quarter.
- Across five years, Enterprise Value topped out at -$54989.0 in Q4 2025 and bottomed at -$1.7 million in Q2 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Enterprise Value (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | -6.66 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | -2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | -8.61 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | -1.21 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | -3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | -1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | -2.07 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | -577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | -3.09 Bn |
| 10 | Phaos Technology Holdings (Cayman) | 6.05 Mn | 5.99 Mn | - | -54,989.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Oct 31, 2025 | -54,989.00 |
| Apr 30, 2025 | -96,918.26 |
| Apr 30, 2024 | -1.72 Mn |